Share & more
A media report saying research had found that pregnant women using the anti-AIDS drug, Nevirapine, could develop resistance to future use of HIV/AIDS drugs, has raised concern in South Africa.
The findings were presented at the 11th Annual Retrovirus Conference, held recently in San Francisco in the US.
According to BuaNews, a local news service, Nevirapine was currently being used in the government's national programme for the prevention of mother-to-child transmission (PMTCT) of HIV at 18 pilot sites.
Health Minister Manto Tshabalala-Msimang responded by saying she had referred these concerns to the Medicines Control Council (MCC) for investigation as soon as possible, and would be advised of their findings.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions